Inventor · disambiguated record
Friedrich Dorner
Also filed as: DORNER FRIEDRICH
92 granted patents·14 pending applications·2,878 citations·filing 1975–2018
99Inventor score
Top patents by PatentIndex Score
106 records- 0199US6936441B2Recombinant cell clones having increased stability and methods of making and using the sameBAXTER AG·Filed 2002·Granted Aug 30, 2005·160 cites·27 claims
- 0298US9714411B2Animal protein-free media for cultivation of cellsBAXALTA INC·Filed 2015·Granted Jul 25, 2017·16 cites·18 claims
- 0397US7094574B2Recombinant cell clones having increased stability and methods of making and using the sameBAXTER AG·Filed 2005·Granted Aug 22, 2006·32 cites·10 claims
- 0496US6475725B1Recombinant cell clones having increased stability and methods of making and using the sameBAXTER AG·Filed 1999·Granted Nov 5, 2002·119 cites·34 claims
- 0596US6100061ARecombinant cell clone having increased stability in serum- and protein-free medium and a method of recovering the stable cell clone and the production of recombinant proteins by using a stable cell cloneIMMUNO AG·Filed 1998·Granted Aug 8, 2000·229 cites·44 claims
- 0695US9809796B2Animal protein-free media for cultivation of cellsBAXALTA INC·Filed 2017·Granted Nov 7, 2017·13 cites·19 claims
- 0795US7033590B1Factor IX/factor IXa activating antibodies and antibody derivativesBAXTER AG·Filed 2000·Granted Apr 25, 2006·47 cites·22 claims
- 0894US8021881B2Medium for the protein-free and serum-free cultivation of cellsBAXTER INNOVATIONS GMBH·Filed 2007·Granted Sep 20, 2011·13 cites·13 claims
- 0993US5770212ARecombinant poxviruses with foreign DNA in essential regionsIMMUNO AG·Filed 1997·Granted Jun 23, 1998·123 cites·19 claims
- 1093US5753489AMethod for producing viruses and vaccines in serum-free cultureIMMUNO AG·Filed 1995·Granted May 19, 1998·133 cites·8 claims
- 1192US6635246B1Inactivated influenza virus vaccine for nasal or oral applicationBAXTER HEALTHCARE SA·Filed 2000·Granted Oct 21, 2003·87 cites·20 claims
- 1292US6372223B1Influenza virus vaccine compositionBAXTER AG·Filed 1999·Granted Apr 16, 2002·101 cites·8 claims
- 1391US10138461B2Animal protein-free media for cultivation of cellsBAXALTA INC·Filed 2017·Granted Nov 27, 2018·2 cites·15 claims
- 1491US9222075B2Animal protein-free media for cultivation of cellsBAXTER INT·Filed 2014·Granted Dec 29, 2015·4 cites·7 claims
- 1591US8440408B2Animal protein-free media for cultivation of cellsGRILLBERGER LEOPOLD·Filed 2010·Granted May 14, 2013·5 cites·4 claims
- 1691US8084252B2Recombinant cell clones having increased stability and methods of making and using the sameREITER MANFRED·Filed 2010·Granted Dec 27, 2011·5 cites·21 claims
- 1791US6146873AProduction of orthomyxoviruses in monkey kidney cells using protein-free mediaBAXTER AG·Filed 1997·Granted Nov 14, 2000·158 cites·37 claims
- 1890US7279161B2Factor IX/factor IXa activating antibodies and antibody derivativesBAXTER AG·Filed 2005·Granted Oct 9, 2007·6 cites·9 claims
- 1990US7052701B2Inactivated influenza virus vaccine for nasal or oral applicationBAXTER HEALTHCARE SA·Filed 2005·Granted May 30, 2006·10 cites·16 claims
- 2090US6228613B1Stable factor VIII/von Willebrand factor complexBAXTER AG·Filed 1997·Granted May 8, 2001·53 cites·40 claims
- 2189US7220569B2Nucleic acids encoding factor X analogues having a modified protease cleavage siteBAXTER AG·Filed 2003·Granted May 22, 2007·37 cites·16 claims
- 2289US6861244B2Inactivated influenza virus vaccine for nasal or oral applicationBAXTER HEALTHCARE SA·Filed 2003·Granted Mar 1, 2005·21 cites·1 claims
- 2388US8080414B2Recombinant cell clones having increased stability and methods of making and using the sameREITER MANFRED·Filed 2009·Granted Dec 20, 2011·3 cites·22 claims
- 2487US5854403AMethod for isolation of highly pure von Willebrand FactorIMMUNO AG·Filed 1996·Granted Dec 29, 1998·53 cites·16 claims
- 2587US4184917AProcess for producing a structurally modified interferonSANDOZ AG·Filed 1977·Granted Jan 22, 1980·42 cites·5 claims
- 2686US6114146AExpression plasmid, a fusion protein, a transfected eukaryotic cell line, a method of producing foreign proteins, a foreign protein preparation as well as a pharmaceutical compositionBAXTER AG·Filed 1995·Granted Sep 5, 2000·94 cites·31 claims
- 2785US5869617AHigh and low molecular weight fractions of von Willebrand Factor and preparations of sameIMMUNO AG·Filed 1995·Granted Feb 9, 1999·47 cites·19 claims
- 2884US4640834AMethod of inactivating reproducible filterable pathogens in blood products as well as a method of producing blood productsIMMUNO AG·Filed 1985·Granted Feb 3, 1987·144 cites·20 claims
- 2983US6855535B2Method of large scale production of Hepatitis A virusBAXTER HEALTHCARE SA·Filed 2001·Granted Feb 15, 2005·9 cites·13 claims
- 3083US6210929B1Fusion protein comprising a furin derivative or a derivative of a furin analogue and a heterologous sequenceBAXTER AG·Filed 1996·Granted Apr 3, 2001·43 cites·22 claims
- 3182US6905846B2Nucleic acids encoding factor X deletion mutants and analogues thereofBAXTER AG·Filed 2003·Granted Jun 14, 2005·15 cites·17 claims
- 3281US6953837B2Factor VIII/vWF complexes and compositionsBAXTER AG·Filed 2001·Granted Oct 11, 2005·12 cites·6 claims
- 3381US6136321AMethod of inactivating lipid-enveloped virusesBAXTER AG·Filed 1998·Granted Oct 24, 2000·50 cites·16 claims
- 3480US5670367ARecombinant fowlpox virusIMMUNO AG·Filed 1994·Granted Sep 23, 1997·53 cites·9 claims
- 3579US8722406B2Medium for the protein-free and serum-free cultivation of cellsREITER MANFRED·Filed 2011·Granted May 13, 2014·1 cites·16 claims
- 3679US5530103AMethod for the purification of PC protein from Borrelia burgdorferiIMMUNO AG·Filed 1993·Granted Jun 25, 1996·40 cites·1 claims
- 3778US6924151B2Stable factor VIII/vWF-complexBAXTER AG·Filed 2001·Granted Aug 2, 2005·3 cites·13 claims
- 3878US6103244AMethods for generating immune responses employing modified vaccinia of fowlpox virusesBAXTER AG·Filed 1996·Granted Aug 15, 2000·36 cites·14 claims
- 3978US5766882Arecombinant poxviruses with foreign DNA in essential regionsIMMUNO AG·Filed 1996·Granted Jun 16, 1998·42 cites·44 claims
- 4078US5756341AMethod for controlling the infectivity of virusesIMMUNO AG·Filed 1995·Granted May 26, 1998·52 cites·26 claims
- 4177US10655099B2Animal protein-free media for cultivation of cellsBAXALTA INC·Filed 2018·Granted May 19, 2020·0 cites·18 claims
- 4275USRE46745ERecombinant cell clones having increased stability and methods of making and using the sameBAXTER INNOVATIONS GMBH·Filed 2014·Granted Mar 6, 2018·0 cites·16 claims
- 4375US4946677APreparations active against pseudomonas aeruginosa infections and methods of producing themIMMUNO AG·Filed 1987·Granted Aug 7, 1990·28 cites·7 claims
- 4474US6103693AMethod for isolation of highly pure von willebrand factorBAXTER AG·Filed 1997·Granted Aug 15, 2000·27 cites·13 claims
- 4573US6573071B1Factor X analogues with a modified protease cleavage siteBAXTER AG·Filed 1998·Granted Jun 3, 2003·29 cites·64 claims
- 4673US5858658AMethod of quantitating genomic DNAIMMUNO AG·Filed 1995·Granted Jan 12, 1999·52 cites·23 claims
- 4773US5445953ADirect molecular cloning of a modified poxvirus genomeIMMUNO AG·Filed 1991·Granted Aug 29, 1995·41 cites·26 claims
- 4872US6562598B1Factor X deletion mutants and analogues thereofBAXTER AG·Filed 1998·Granted May 13, 2003·27 cites·56 claims
- 4972US5880265AMethod for isolation of highly pure von willebrand factorIMMUNO AG·Filed 1997·Granted Mar 9, 1999·22 cites·7 claims
- 5072US5633350AMethod for the isolation and purification of vitamin K-dependent proteinsIMMUNO AG·Filed 1995·Granted May 27, 1997·24 cites·17 claims
Showing the top 50 of 106 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →